Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression
Authors
Keywords
-
Journal
BLOOD
Volume 118, Issue 1, Pages 167-176
Publisher
American Society of Hematology
Online
2011-05-01
DOI
10.1182/blood-2011-01-331678
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p53 Lesions in Leukemic Transformation
- (2011) Ashot Harutyunyan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
- (2010) S. T. Oh et al. BLOOD
- Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms
- (2010) N. H. Thoennissen et al. BLOOD
- LNK mutation studies in blast-phase myeloproliferative neoplasms and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations
- (2010) A Pardanani et al. LEUKEMIA
- Deletions of the transcription factor Ikaros in myeloproliferative neoplasms
- (2010) R Jäger et al. LEUKEMIA
- Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
- (2010) Gorica Nikoloski et al. NATURE GENETICS
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- Somatic Mutations ofIDH1andIDH2in the Leukemic Transformation of Myeloproliferative Neoplasms
- (2010) Anthony Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms
- (2009) Y. Ding et al. BLOOD
- Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm
- (2009) P. A. Beer et al. BLOOD
- Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance
- (2009) Naseema Gangat et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Conventional cytogenetics in myelofibrosis: literature review and discussion
- (2009) Kebede Hussein et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations
- (2009) F. Stegelmann et al. HAEMATOLOGICA
- Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
- (2009) Constantine S. Tam et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutations of ASXL1 gene in myeloproliferative neoplasms
- (2009) N Carbuccia et al. LEUKEMIA
- TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
- (2009) A Tefferi et al. LEUKEMIA
- Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms
- (2009) Masashi Sanada et al. NATURE
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole genome scanning as a cytogenetic tool in hematologic malignancies
- (2008) J. P. Maciejewski et al. BLOOD
- JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders
- (2008) I. Plo et al. BLOOD
- 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
- (2008) A. J. Dunbar et al. CANCER RESEARCH
- Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates
- (2008) Naseema Gangat et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- AML transformation in 56 patients with Ph− MPD in two well defined populations
- (2008) Khadija Abdulkarim et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofibrosis
- (2008) Veronika Buxhofer-Ausch et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation
- (2008) H Szpurka et al. LEUKEMIA
- Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs)
- (2008) J T Reilly LEUKEMIA
- p110 CUX1 Cooperates with E2F Transcription Factors in the Transcriptional Activation of Cell Cycle-Regulated Genes
- (2008) M. Truscott et al. MOLECULAR AND CELLULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started